日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway

MSMO1通过PERK/eIF2α/ATF4/CHOP通路调控T-MAS代谢,从而促进化疗耐药。

Ren, Hengyu; Wang, Xuliren; Shao, Zhibo; Xiong, Min; Chi, Weiru; Sang, Yuting; Zhang, Qi; Wang, Zehao; Liu, Douwaner; Zhang, Liyi; Chen, Ming; Zhu, Han; Xue, Jingyan; Xiu, Bingqiu; Chi, Yayun; Wu, Jiong

XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer.

XBP1s介导乳腺癌中CDK4/6抑制剂联合内分泌治疗的交叉耐药性。

Sang Yuting, Liu Shiyang, Zhou Xujie, Chi Weiru, Xiong Min, Chen Ming, Ren Hengyu, Liu Douwaner, Zhang Liyi, Xue Jingyan, Chi Yayun, Wu Jiong

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer.

LINC01235 通过 DNA 复制许可诱导的染色体不稳定性促进乳腺癌的克隆进化

Zhang Qi, Wang Xuliren, Shao Zhibo, Zhang Yi, Zhang Liyi, Chen Ming, Zhou Xujie, Zhu Han, Zhou Yue, Lu Xinya, Li Pei, Chi Weiru, Li Lun, Shao Zhi-Ming, Huang Shenglin, Xue Jingyan, Chi Yayun, Wu Jiong, Xiu Bingqiu

PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer

PPARG激活脂肪酸代谢驱动HER2阳性乳腺癌对HER2抑制剂的耐药性

Xiong, Min; Liu, Douwaner; Wang, Xuliren; Ren, Hengyu; Chi, Weiru; Xiu, Bingqiu; Zhang, Qi; Zhang, Jiayu; Zhang, Liyi; Wang, Zehao; Chen, Ming; Xue, Jingyan; Chi, Yayun; Wu, Jiong

JCAD-Derived from Plasma Exosomes: Promoting Tumor Cell Progression and Predicting Poor Outcomes in Breast Cancer

源自血浆外泌体的JCAD:促进肿瘤细胞进展并预测乳腺癌不良预后

Liu, Douwaner; Xiong, Min; Chen, Xiaoting; Wang, Xuliren; Sang, Yuting; Liu, Shiyang; Zhang, Liyi; Chi, Weiru; Ren, Hengyu; Xiu, Bingqiu; Zhang, Qi; Chi, Yayun; Wu, Jiong; Xue, Jingyan

Assessing neoadjuvant treatment response through serum human epidermal growth factor receptor 2 (HER2) dynamics

通过血清人表皮生长因子受体2 (HER2) 动态变化评估新辅助治疗反应

Wang, Xuliren; Xiong, Min; Shao, Zhibo; Xiu, Bingqiu; Zhang, Qi; Liu, Douwaner; Chi, Weiru; Zhang, Liyi; Chen, Ming; Ren, Hengyu; Shao, Zhi-Ming; Chen, Jiajian; Wu, Jiong

Somatic mutations in a multigene panel and impact on prognosis based on TP53 status in Chinese HER2-positive patients undergoing neoadjuvant therapy: A single-institution retrospective cohort

基于TP53状态的多基因panel体细胞突变对接受新辅助治疗的中国HER2阳性患者预后的影响:一项单中心回顾性队列研究

Xiong, Min; Wang, Xuliren; Liu, Douwaner; Xiu, Bingqiu; Zhang, Qi; Chi, Weiru; Goh, Chih Wan; Zhang, Liyi; Chen, Ming; Ren, Hengyu; Shao, Zhi-Ming; Yang, Benlong; Wu, Jiong

Immediate Breast Reconstruction After Neoadjuvant Chemotherapy: Factors Associated With Surgical Selection and Complications

新辅助化疗后即刻乳房重建:手术选择及并发症相关因素

Chi, Weiru; Zhang, Qi; Li, Lun; Chen, Ming; Xiu, Bingqiu; Yang, Benlong; Wu, Jiong

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization

免疫抑制性长链非编码RNA LINC00624通过ADAR1稳定促进肿瘤进展和治疗耐药性

Zhang, Qi; Xiu, Bingqiu; Zhang, Liyi; Chen, Ming; Chi, Weiru; Li, Lun; Guo, Rong; Xue, Jingyan; Yang, Benlong; Huang, Xiaoyan; Shao, Zhi-Ming; Huang, Shenglin; Chi, Yayun; Wu, Jiong

Author Correction: Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer

作者更正:血浆细胞外囊泡长链RNA谱在乳腺癌诊断和治疗反应预测中的应用

Su, Yonghui; Li, Yuchen; Guo, Rong; Zhao, Jingjing; Chi, Weiru; Lai, Hongyan; Wang, Jia; Wang, Zhen; Li, Lun; Sang, Yuting; Hou, Jianjing; Xue, Jingyan; Shao, Zhimin; Chi, Yayun; Huang, Shenglin; Wu, Jiong